Addictions, Drug & Alcohol Institute

Front Page

November 23, 2022

New from ADAI: Provider Perspectives on Medication Treatment for OUD in Adolescents

New from ADAI: Perspectives on Medication Treatment for OUD in Adolescents: Results from a Provider Learning Series. Peavy KM, Adwell A, Owens MD, Banta-Green CJ. Subst Use Misuse 2022 (in press)

Despite recent surges in adolescent opioid use disorder (OUD), teens are less likely to enter treatment compared to adults, and are rarely in treatment settings that offer evidence-based medication treatment (methadone, buprenorphine, and naltrexone). Buprenorphine is the only medication approved for people under 18 (aged 16 and older) and methadone requires written parental consent for…

November 10, 2022

Looking for ADAI Events?

Photo of person holding phone in one hand and writing on calendar with other

Looking for upcoming events hosted by the UW Addictions, Drug & Alcohol Institute? You can find our events a few different ways: Subscribe to the ADAI News & Events blog (this!) and get notices about events hosted by ADAI and its various centers and teams (CEDEER, CAAHS and the Northwest ATTC, CERP, CTN, and more!),…

November 8, 2022

New ADAI Report: Overdose Deaths Involving Prescription Opioids in WA, 2010-2021

New ADAI report: Overdose deaths involving pharmaceutical opioids in WA State from 2010-2021

This new report by Caleb Banta-Green, PhD, MPH, MSW and Jason Williams, PhD of the ADAI Center for Community-Engaged Drug Education, Epidemiology & Research (CEDEER) examines key indicators related to pharmaceutical opioids including sales data and overdose death rates. Key Points Prescription opioid overdose deaths declined from their peak in 2006, but are higher than…

November 7, 2022

New Research from ADAI: Opioid Safety Intervention for Community Pharmacists

New Research from ADAI

ADAI Research Associate Professor Anthony Floyd, PhD has a new paper out describing an assessment of community pharmacists’ readiness to implement an educational program that aims to boost their knowledge and confidence when it comes to providing opioid safety and harm reduction services to patients and customers. What is the context for this study? Community…

November 4, 2022

How Can We Solve King County’s Fentanyl Problem? Seattle Met Article Feat. Caleb Banta-Green

Seattle Met: How Can We Solve King County's Fentanyl Problem?

Seattle Met magazine has two new stories about fentanyl in King County, both by Angela Cabotaje. The first, “How Can We Solve King County’s Fentanyl Problem?,” features ADAI Acting Professor Caleb Banta-Green, PhD, MPH, MSW, describing the impact pharmaceutical companies had on the opioid overdose crisis, and the innovative program Bupe Pathways, which is helping…

ADAI Hiring for 3 Open Positions!

Bullhorn with "We're hiring" in a talk bubble

ADAI is currently recruiting for 3 open positions! Here’s the information: Administrative Assistant (60% FTE) Update: this position has closed! This position supports the administrative staff, research scientists, faculty, and the information team at ADAI with a range of tasks, including general administrative assignments, scheduling meetings, contributing to written materials and web page content, helping…

November 1, 2022

ADAI Lunch & Learn: Improving Interactions Between Law Enforcement and People Who Use Substances (Nov 16, 12pm)

ADAI Lunch & Learn Series

Please join us on November 16 (12-1pm PT) for our next ADAI Lunch & Learn session, featuring ADAI Assistant Professor Mandy Owens, PhD. In this talk, Dr. Owens will introduce and provide updates on two ongoing projects with law enforcement: a) developing training content on substance use disorders for the statewide basic law enforcement academy,…

ADAI’s Bia Carlini, PhD Interviewed on Q13 About High-THC Cannabis Products

Bia Carlini screenshot of Q13 interview

Acting Associate Professor Beatriz Carlini, PhD, director of ADAI’s Cannabis Education & Research Program (CERP), was recently interviewed for Q13 FOX about the health risks of high-THC cannabis products. Dr. Carlini talks in the video about how cannabis legalization brought new jobs and less criminalization of individuals, both good things, but that the market has…

October 27, 2022

Webinar: Drug Trends (Nov. 16, 12pm PT)

Upcoming ADAI Event: Washington State Drug Trends. November 16, 2022, 12-1pm PT

ADAI is offering a 4-part quarterly webinar series covering the latest topics on treating opioid use disorder and related subjects in Washington State. These virtual 60-minute sessions can support you in developing your skills to work with patients who have opioid use disorder. The first presentation, Drug Trends, will be presented by Caleb Banta-Green, PhD,…

October 24, 2022

Join the ADAI CERP Team: Seeking Full-Time, Master’s Level Research Scientist

ADAI is Hiring! Research Scientist/Program Evaluator for CERP (full-time)

The Cannabis Education & Research Program (CERP) at the Addictions, Drug & Alcohol Institute (ADAI), which is partially funded by the WA State Dedicated Cannabis Fund for research at the UW (since 2015), is comprised of investigators and program staff who have come together to collaborate on research and dissemination activities in response to emerging…

Next page